Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 20 Lymphoma 17 Neoplasm Metastasis 14 Leukemia, Myeloid, Acute 12 Pancreatic Neoplasms 9 Breast Neoplasms 9 Ovarian Neoplasms 8 Melanoma 8 Lung Neoplasms 8 Colorectal Neoplasms 8 Sarcoma 7 Prostatic Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Glioma 7 Fallopian Tube Neoplasms 7 Cholangiocarcinoma 7 Neuroblastoma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Endometrial Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Ependymoma 5 Burkitt Lymphoma 5 Wilms Tumor 4 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rhabdomyosarcoma 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4

Interventions

Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 liposomal doxorubicin 1 dehydroftorafur 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 Zidovudine 1 X-Rays 1 Vincristine 1 Valganciclovir 1 Sirolimus 1 Sigmoidoscopy 1 Sentinel Lymph Node Biopsy 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Proctoscopy 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Mitozytrex 1 Mitomycin 1 Melphalan 1 Interferon-alpha 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 Filgrastim 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × HIV Infections × Biopsy × Clear all

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡